MRA/MRI-NSF Injury Attorneys

The MRA/MRA-NSF injury attorneys at Parker Waichman LLP have been investigating the link between NSF and Gadolinium Contrast Dyes used n Magnetic Resonance Imaging (MRI). NSF is a rare and debilitating disease seen in patients with pre-existing kidney problems. The first Gadolinium Contrast Dyes used in MRIs where approved by the Food & Drug Administration in the mid 1980s. It wasn’t until 1997 that the first case of NSF was diagnosed, and the disease did not appear in medical literature until 2000. Unfortunately, because NSF is a relatively new and rare disease, not much research has been done on the disorder. But the studies that have been done have found a direct correction between NSF and the Gadolinium Contrast Dyes used in many MRI procedures.